38 related articles for article (PubMed ID: 32624414)
1. Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma.
Dozin B; Carbotti G; Roncella S; Ferro P; Dessanti P; Canessa PA; Ferrini S; Fabbi M
Cancer Immunol Immunother; 2021 Nov; 70(11):3349-3355. PubMed ID: 34003301
[TBL] [Abstract][Full Text] [Related]
2. Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach.
Lisini D; Lettieri S; Nava S; Accordino G; Frigerio S; Bortolotto C; Lancia A; Filippi AR; Agustoni F; Pandolfi L; Piloni D; Comoli P; Corsico AG; Stella GM
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445720
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infection in malignant pleural mesothelioma.
Hunter-Schlichting D; Kelsey KT; Demmer R; Patel M; Bueno R; Christensen B; Fujioka N; Kolarseri D; Nelson HH
PLoS One; 2021; 16(8):e0254136. PubMed ID: 34383785
[TBL] [Abstract][Full Text] [Related]
4. Advanced Symptom Management System for Patients with Malignant Pleural Mesothelioma (ASyMSmeso): Mixed Methods Study.
Maguire R; Connaghan J; Arber A; Klepacz N; Blyth KG; McPhelim J; Murray P; Rupani H; Chauhan A; Williams P; McNaughton L; Woods K; Moylan A
J Med Internet Res; 2020 Nov; 22(11):e19180. PubMed ID: 33180025
[TBL] [Abstract][Full Text] [Related]
5. Contemporary issues in the surgical management of pleural mesothelioma.
Paajanen J; Jaklitsch MT; Bueno R
J Surg Oncol; 2023 Feb; 127(2):343-354. PubMed ID: 36630097
[TBL] [Abstract][Full Text] [Related]
6. High tumor cell platelet-derived growth factor receptor beta expression is associated with shorter survival in malignant pleural epithelioid mesothelioma.
Ollila H; Paajanen J; Wolff H; Ilonen I; Sutinen E; Välimäki K; Östman A; Anttila S; Kettunen E; Räsänen J; Kallioniemi O; Myllärniemi M; Mäyränpää MI; Pellinen T
J Pathol Clin Res; 2021 Sep; 7(5):482-494. PubMed ID: 33955203
[TBL] [Abstract][Full Text] [Related]
7. Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel.
Marchevsky AM; Khoor A; Walts AE; Nicholson AG; Zhang YZ; Roggli V; Carney J; Roden AC; Tazelaar HD; Larsen BT; LeStang N; Chirieac LR; Klebe S; Tsao MS; De Perrot M; Pierre A; Hwang DM; Hung YP; Mino-Kenudson M; Travis W; Sauter J; Beasley MB; Galateau-Sallé F
Mod Pathol; 2020 Feb; 33(2):281-296. PubMed ID: 31485011
[TBL] [Abstract][Full Text] [Related]
8. Current concepts in malignant pleural mesothelioma.
Kaufman AJ; Pass HI
Expert Rev Anticancer Ther; 2008 Feb; 8(2):293-303. PubMed ID: 18279069
[TBL] [Abstract][Full Text] [Related]
9. Gender-based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma.
Barsky AR; Ahern CA; Venigalla S; Verma V; Anstadt EJ; Wright CM; Ludmir EB; Berlind CG; Lindsay WD; Grover S; Cengel KA; Simone CB
Clin Lung Cancer; 2020 Nov; 21(6):e583-e591. PubMed ID: 32611504
[TBL] [Abstract][Full Text] [Related]
10. Treatment patterns among patients with malignant pleural mesothelioma: An Italian, population-based nationwide study.
Trama A; Proto C; Signorelli D; Garassino MC; Lo Russo G; Ganzinelli M; Prelaj A; Mensi C; Gangemi M; Gennaro V; Chellini E; Caldarella A; Angelillo IF; Ascoli V; Pascucci C; Tagliabue G; Cusimano R; Bella F; Falcini F; Merler E; Masanotti G; Ziino A; Michiara M; Gola G; Storchi C; Mangone L; Vitale MF; Cirilli C; Tumino R; Scuderi T; Fanetti AC; Piffer S; Tiseo M; Gatta G; Botta L;
Thorac Cancer; 2020 Jun; 11(6):1661-1669. PubMed ID: 32364316
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors influencing survival in 35 patients with malignant peritoneal mesothelioma.
Kaya H; Sezgı C; Tanrıkulu AC; Taylan M; Abakay O; Sen HS; Abakay A; Kucukoner M; Kapan M
Neoplasma; 2014; 61(4):433-8. PubMed ID: 24645844
[TBL] [Abstract][Full Text] [Related]
12. Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion.
Zhang S; Zhang Y; Feng W; Shi Z; Shi H; Zhang Y
Thorac Cancer; 2021 Dec; 12(24):3304-3309. PubMed ID: 34704370
[TBL] [Abstract][Full Text] [Related]
13. The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma.
Asciak R; Kanellakis NI; Bibby A; Kidd A; Gerry S; Mercer R; Maskell N; Blyth KG; Fsadni P; Montefort S; Psallidas I; Rahman NM
Chest; 2021 Nov; 160(5):1925-1933. PubMed ID: 34119515
[TBL] [Abstract][Full Text] [Related]
14. Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses.
Paajanen J; Laaksonen S; Ilonen I; Vehmas T; Mäyränpää MI; Sutinen E; Kettunen E; Salo JA; Räsänen J; Wolff H; Myllärniemi M
Clin Lung Cancer; 2020 Nov; 21(6):e633-e639. PubMed ID: 32624414
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
